57 related articles for article (PubMed ID: 38516243)
1. Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review).
Huang Q; Liang Z; Huang Q; Li X; Xia J; Huang L; Huang LB; Ou C
Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666534
[TBL] [Abstract][Full Text] [Related]
2. Lipid metabolism-related long noncoding RNA RP11-817I4.1 promotes fatty acid synthesis and tumor progression in hepatocellular carcinoma.
Wang RY; Yang JL; Xu N; Xu J; Yang SH; Liang DM; Li JZ; Zhu H
World J Gastroenterol; 2024 Feb; 30(8):919-942. PubMed ID: 38516243
[TBL] [Abstract][Full Text] [Related]
3. A novel lncRNA RP11-386G11.10 reprograms lipid metabolism to promote hepatocellular carcinoma progression.
Xu K; Xia P; Gongye X; Zhang X; Ma S; Chen Z; Zhang H; Liu J; Liu Y; Guo Y; Yao Y; Gao M; Chen Y; Zhang Z; Yuan Y
Mol Metab; 2022 Sep; 63():101540. PubMed ID: 35798238
[TBL] [Abstract][Full Text] [Related]
4. RP11-295G20.2 facilitates hepatocellular carcinoma progression via the miR-6884-3p/CCNB1 pathway.
Li J; Xia T; Cao J; He D; Chen Z; Liang B; Song J
Aging (Albany NY); 2020 Jul; 12(14):14918-14932. PubMed ID: 32687483
[TBL] [Abstract][Full Text] [Related]
5. A novel long non-coding RNA RP11-286H15.1 represses hepatocellular carcinoma progression by promoting ubiquitination of PABPC4.
Jiang X; Wang G; Liu Y; Mei C; Yao Y; Wu X; Chen X; Ma W; Li K; Zhang Z; Yuan Y
Cancer Lett; 2021 Feb; 499():109-121. PubMed ID: 33259899
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HOTAIR promotes hepatocellular carcinoma progression by regulating miR-526b-3p/DHX33 axis.
Liu Z; Ouyang G; Lu W; Zhang H
Genes Genomics; 2021 Aug; 43(8):857-868. PubMed ID: 33843021
[TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
8. Disulfidptosis-related lncRNA signatures assess immune microenvironment and drug sensitivity in hepatocellular carcinoma.
Xu K; Dai C; Yang J; Xu J; Xia C; Li J; Zhang C; Xu N; Wu T
Comput Biol Med; 2024 Feb; 169():107930. PubMed ID: 38199215
[TBL] [Abstract][Full Text] [Related]
9. LncRNA TGFB2-OT1 Promotes Progression and Angiogenesis in Hepatocellular Carcinoma by Dephosphorylating β-Catenin.
Chen Y; Wu X; Chen X; Guo D; Ma W; Guo Y; Xu K; Ma S; Yuan Y; Zhu Q
J Hepatocell Carcinoma; 2023; 10():429-446. PubMed ID: 36941998
[TBL] [Abstract][Full Text] [Related]
10. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.
Xia P; Zhang H; Lu H; Xu K; Jiang X; Jiang Y; Gongye X; Chen Z; Liu J; Chen X; Ma W; Zhang Z; Yuan Y
Cancer Commun (Lond); 2023 Mar; 43(3):338-364. PubMed ID: 36602428
[TBL] [Abstract][Full Text] [Related]
11. A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma.
Xu K; Xia P; Liu P; Zhang X
Sci Rep; 2022 Dec; 12(1):20781. PubMed ID: 36456877
[TBL] [Abstract][Full Text] [Related]
12. Prognostic signature of lipid metabolism associated LncRNAs predict prognosis and treatment of lung adenocarcinoma.
Zhao J; Li G; Zhao G; Wang W; Shen Z; Yang Y; Huang Y; Ye L
Front Oncol; 2022; 12():986367. PubMed ID: 36387240
[TBL] [Abstract][Full Text] [Related]
13. Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer.
Lin Y; Xiao Y; Liu S; Hong L; Shao L; Wu J
BMC Med Genomics; 2022 Oct; 15(1):221. PubMed ID: 36280825
[TBL] [Abstract][Full Text] [Related]
14. Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling.
Duan J; Huang Z; Nice EC; Xie N; Chen M; Huang C
J Adv Res; 2023 Jun; 48():105-123. PubMed ID: 35973552
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]